THE GENETIC REVOLUTION IN VACCINES: DNA VACCINES AND THEIR IMPACT ON INFECTIOUS DISEASE CONTROL

Abstract

DNA vaccines target viral genes to activate the immune system, offering advantages such as scalability, rapid development, and broad immunogenicity. Despite challenges in delivery methods and immunosuppression optimization, DNA vaccines remain relevant alongside mRNA vaccines due to their unique properties and continuous improvements. The genetic revolution in vaccines has led to the development of DNA vaccines, which have shown promise in treating infectious diseases, cancer, and autoimmune diseases. DNA vaccines are affordable, easy to manufacture, and can be produced in a short time, making them a valuable tool in disease control. The article discusses the significance of conjugate vaccines, recombinant vector vaccines, and the promising role of DNA-mediated immunity in enhancing immunotherapy for various diseases. Overall, the insights provided underscore the transformative potential of DNA vaccines in revolutionizing global health outcomes. The article concludes by discussing the potential of DNA vaccines in addressing the challenges of constant pathogen mutations and emerging diseases, and the ongoing research in DNA vaccine technology to improve efficacy and safety